Tag Archives: Pharmacogenomics Market

****** Pharmacogenomics Market to reach a market size of $9.9 billion by 2025- KBV Research

According to a new report ****** Pharmacogenomics Market, published by KBV research, The ****** Pharmacogenomics Market size is expected to reach $9.9 billion by 2025, rising at a market growth of 8.8% CAGR during the forecast period.

The Hospitals and Clinics market dominated the ****** Pharmacogenomics Market by End User in 2018, growing at a CAGR of 8.5 % during the forecast period. The Research Institutions market is expected to witness highest CAGR of 9.1% during (2019-2025).

Pharmacogenomics Market Anticipated to Grow at an Impressive Rate

Pharmacogenomics Market is projected to reach $10,265.5 million by 2025, growing at a CAGR of 8.61% from 2018 to 2025.

Pharmacogenomics is the field of science that deals with the role of genes in a drug response in an individual. The increase in the number of pharmacogenomics-based tests due to growth in ailments, such as cancer, tuberculosis, Alzheimers disease, cardiovascular diseases, and other mortality causing diseases, is expected to boost the market growth. The market for pharmacogenomics has witnessed tremendous growth in the recent years, owing to rise in patient preference toward personalized therapy-based medications.



****** Pharmacogenomics Market Is Expected To Reach USD 11.94 Bn By 2024

The latest market report published by Credence Research, Inc. “****** Pharmacogenomics Market – Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 – 2023,” the ****** pharmacogenomics market was valued at US$ 7,167.6 Mn in 2015, and is expected to reach US$ 11,938.8 Mn by 2024, expanding at a CAGR of 5.6% from 2016 to 2024.

Browse the full report ****** Pharmacogenomics Market – Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 – 2024 at http://www.credenceresearch.com/report/pharmacogenomic-market

Market Insights